Recent research from the labs of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, has been published in Cell Reports Medicine. (Photo by Danny Palomba/Office of Communications)
A translational research study from collaborating laboratories of Mikhail Kolonin, PhD, and Absalon Gutierrez, MD, on the new mechanism mediating the anti-diabetic effects of incretins has been published in Cell Reports Medicine.
The global burden of Type 2 diabetes keeps rising in parallel with the increasing prevalence of obesity, a condition of white adipose tissue overgrowth. Frontline treatments include lifestyle changes, as well as the administration of insulin and of other glucose-lowering molecules that work through various mechanisms.
Read more…